Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer

This study has been terminated.
(Lack of accrual)
Sponsor:
Collaborators:
University of Colorado, Denver
M.D. Anderson Cancer Center
Northwell Health
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01354951
First received: May 16, 2011
Last updated: June 29, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: May 2017
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)